alexa Subconjunctival Bevacizumab Versus Mitomycin C Adjunctive To Trabeculectomy In Primary Open Angle Glaucoma
ISSN: 2155-9570

Journal of Clinical & Experimental Ophthalmology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

10th International conference on Ophthalmology and Optometry
August 10-11, 2017 Beijing, China

Islam Goda, Hassan Lotfy, Mohammed Sayed, Abdelsalam Abdallah and Mahmoud Abd El-Radi
Assiut University, Egypt
Posters & Accepted Abstracts: J Clin Exp Ophthalmol
DOI: 10.4172/2155-9570-C1-064
Abstract
This study is to compare the efficacy and safety of Mitomycin C versus Bevacizumab as adjunctive to trabeculectomy in primary open angle glaucoma. A prospective, comparative, open-label study was conducted at Assiut University Hospital in Egypt from January 2014 to November 2016. 30 eyes from 30 patients with uncontrolled primary open angle glaucoma were enrolled. 15 eyes underwent trabeculectomy with subconjunctival Bevacizumab injection (1.25 mg/0.05 mL) and 15 eyes underwent trabeculectomy with MMC (0.02% for 3 minutes). The primary outcome measure was IOP while the secondary outcome measures were number of IOP lowering medications and bleb morphologic features (based on the Indiana Bleb Appearance Grading Scale). Follow-up times were six months. The mean preoperative IOP in the Bevacizumab group decreased from 29.80±2.83 mmHg with 2.67±0.98 anti-glaucoma medications to 14.13±5.58 mmHg with 1.00±1.13 antiglaucoma medications at the last visit (P<0.001 and P<0.001, respectively). The mean preoperative IOP in the MMC group decreased from 28.40±2.06 mmHg with 2.40±0.99 anti-glaucoma medications to 12.27±4.85 mmHg with 0.87±1.06 antiglaucoma medications at the final visit (P<0.001 and P<0.001, respectively). There was no statistically significant difference in the IOP between the two groups at the last visit (P<0.250). The cumulative probabilities of total success at the last follow-up according to Kaplan-Meier analysis were 86.7% and 79.9% in MMC and Bevacizumab groups, respectively.
Biography

Islam Goda has completed his Master’s degree in Ophthalmology from Assiut University and currently registered as Doctorate in Assiut University, Egypt.

Email: [email protected]

image PDF   |   image HTML
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords